THE RELATIONSHIP BETWEEN THE USE OF INJECTABLE HORMONAL CONTRACEPTION AND THE INCIDENCE OF MELASMA IN WOMEN AGE  30-50 YEARS OLD AT SURANTIAH COMMUNITY HEALTH CENTER PESISIR SELATAN 2024-2025

Irma Primawati; Atiqah Risyia; Irdawaty Izrul; Fitra Deny

doi:10.59003/nhj.v5i8.1824

Authors

Irma Primawati Universitas Baiturrahmah
Atiqah Risyia Universitas Baiturrahmah
Irdawaty Izrul Universitas Baiturrahmah
Fitra Deny Universitas Baiturrahmah

DOI:

https://doi.org/10.59003/nhj.v5i8.1824

Keywords:

Age, Injectable Hormonal Contraceptives, Duration of Use, Melasma Incidence

Abstract

Ultraviolet light exposure and hormonal imbalances have been identified as the main causes of melasma. The use of hormonal contraceptives is also suspected to be a risk factor for melasma, through an imbalance of estrogen and progesterone hormones, which triggers increased skin pigmentation. Aims of this research to determine the relationship between the use of injectable hormonal contraceptives and the incidence of melasma in women aged 30-50 years old at the Surantiah Pesisir Selatan Community Health Center in 2024-2025. This study was an observational analytic study. The accessible population was women aged 30-50 years old using 1-month and 3-month injectable contraceptives who visited the Surantiah Pesisir Selatan Community Health Center between November 2024 and July 2025. The sampling technique used was purposive sampling. Univariate data analysis was presented in the form of frequency distributions, while bivariate analysis used the chi-square test. Data processing was performed using the computerized SPSS program IBM version 25.0. The highest age was 35-39 years old, namely 18 people (26.9%), the highest use of hormonal contraceptives was injectable progestin injections (3 months), namely 46 people (68.7%), the highest incidence of melasma was mild, namely 28 people (41.8%), the highest duration of use was 1-3 years and >3 years, namely 32 people (47.8%) and there is the relationship between the use of injectable hormonal contraceptives and the incidence of melasma in women aged 30-50 years old at the Surantiah Pesisir Selatan Community Health Center in 2024-2025 (p=0.022). There is the relationship between the use of injectable hormonal contraceptives and the incidence of melasma in women age 30-50 years old at the Surantiah Pesisir Selatan Community Health Center in 2024-2025.

Downloads

Download data is not yet available.

References

Ministry of Health of the Republic of Indonesia. Understanding What is Family Planning?; 2023.

Directorate of Family Health. Guidelines for Contraceptive and Family Planning Services. Directorate of Family Health, Ministry of Health of the Republic of Indonesia. 2021;1(11):1-286.

BP Statistics. Percentage of Married Women Aged 15-49 Who Are Currently Using/Using Contraceptives (Percent), 2021-2023; 2024. https://www.bps.go.id

Central Statistics Agency of Pesisir Selatan Regency. New Family Planning Acceptors by Type, 2022 [Internet]. Painan: BPS Pesisir Selatan Regency; 2023 Apr 10 [cited 2025 Jul 30]. Available from:https://pesselkab.bps.go.id/id/statistics-table/2/MTQ0IzI=/akseptor-kb-baru-menurut-jenis-akseptor-.html.

Sinta A, Gita P. The relationship between the use of injectable hormonal contraceptives and the incidence of melasma in the independent practice of midwife Luh Ayu Koriawati. Published online 2023.

Wu MX, Antony R, Mayrovitz HN. Melasma: A Condition of Asian Skin. Cureus. 2021;13(4):1-9. doi:10.7759/cureus.14398

Nur Triyanti M. Review of the Efficacy of Oral Tranexamic Acid for Melasma Therapy. Mirror of the World of Medicine. 2022;49(8):465-468. doi:10.55175/cdk.v49i8.290

Nguyen J, Remyn L, Chung IY, Honigman A, Gourani-Tehrani S, Wutami I, et al. Evaluation of the efficacy of cysteamine cream compared to hydroquinone in the treatment of melasma: A randomized, double-blinded trial. Australas J Dermatol. 2021;62(1):e41–6.

Muslimah, Mufidati HR, Indrastiti R, Handaria D, Swasty, Noviasari NA. Incidence Rate of Melasma Due to Hormonal Contraceptive Use at Tlogosari Kulon Community Health Center. Proceedings of the UNIMUS National Seminar. 2023;6:466-472.

Danil R, Jusuf NK, Putra IB. Prevalence of the Five Most Common Skin Disorders in the Cosmetic Dermatology Polyclinic, University of North Sumatra Hospital, 2020-2022. MDVI [Internet]. 2024Dec.31 [cited 2025Jul.30];51(4). Available from:https://ojs.perdoski.id/index.php/mdvi/article/view/460.

Salim YF, Yenny SW, Lestari S. Incidence of Melasma at the Dermatology and Venereology Polyclinic of Dr. M. Djamil Hospital, Padang, 2012-2015. Andalas Health Journal [Internet]. 2018 Jul. 29 [cited 2025 Jul. 30];7: 71-3. Available from:https://jurnal.fk.unand.ac.id/index.php/jka/article/view/831.

Asditya A, Sukanto H. Profile of Melasma Patients: A Retrospective Study. Periodicals of Dermatology and Venereology. 2017;29(3):220-228.

Amaliyah SR. The Relationship Between Injectable Contraceptive Use and the Incidence of Melasma, Weight Changes, and Menstrual Cycle Disorders. Muhammadiyah University of Purwokerto; 2021.

Pramedisca MA. The Relationship Between History of Hormonal Contraceptive Use and the Degree of Melasma.; 2021. 1–66 pp.

Karomah M. The relationship between the duration of use of 3-month injectable contraceptives and the incidence of melasma in the work area of the Plus Mandiangin Community Health Center, Bukittinggi City in 2019 [Internet]. Bukittinggi: Research and Development Agency of West Sumatra Province; 2019 [cited 2025 Jul 30]. Available from:https://e-riset.sumbarprov.go.id.

Astria N, Rahmawati D. Duration of use and age with the incidence of side effects of the progestin contraceptive Depomedroxy Progesterone Acetate (DMPA) in Women of Childbearing Age. J Maternal and Child Health [Internet]. 2023;2(1):1–6. Available from: http://download.garuda.kemdikbud.go.id/article.php?article=3305637&val=29006&title=Duration of Use and Age with the Occurrence of Side Effects of the Progestin Contraceptive Depomedroxy Progesterone Acetate DMPA in Women of Childbearing Age

Nugroho MA, Lubis TT, Ariati A, Yusria A. The Relationship Between the Duration of Progestin Injection Contraceptive Use and the Menstrual Cycle in Women of Reproductive Age at the Kinali Community Health Center, West Pasaman Regency in 2024. Ibnu Sina J Medicine and Health - Faculty of Medicine, Islamic University of North Sumatra. 2025;24(2):413–20.

Pratiwi RE, Pratamaningtyas S, Rahayu DE. The Relationship between the Use of 3-Month Injectable Contraceptives and Weight Gain in Acceptors: A Literature Study. Indones Heal Issue. 2023;2:1–8.

Mu'min A, Midwifery A, Mashiro LT. Factors Affecting Age of First Sexual Intercourse in Women of Childbearing Age (WUS) (Secondary Data Analysis of the 2017 SDKI). J Obs Sci. 2021;9(2):857-892.

Jannah FW. The Relationship Between Melasma Incidence and the Use of Combined Injectable Hormonal Contraceptives and Combined Pills in Independent Midwife Dwi Astutik, Petungsewu Village, Dau District, Malang Regency. Malang: Faculty of Medicine, Brawijaya University; 2018.

Rahmawaty A, Hidayah L, Pratiwi Y. The Effect of Injectable Contraceptive Type and Duration of Use on Weight Gain in Fertile Age Mothers at the X Bugel Midwife Clinic, Kedung, Jepara. Cendekia J Pharm. 2024;8(1):88–97.

Romauli S, Wijayanti I, Wardhani Y, Pasang N. Experience of Family Planning Acceptors in Using 3-Month Injectable Family Planning in Community Health Centers. J Florence Nightingale Nursing. 2024;7(1):88–102.

Harahap LM. The Relationship Between the Use of Injectable Contraceptives and Weight Gain of KB Acceptors at the Rahmatun Azmi Midwife Clinic, Pargarutan Village, 2021. Published online 2021:1-71.

Raihana R, Isnaniah I, Kristiana E, Rafidah R. The Relationship between the Length of Use of 3-Month Injectable Contraceptives and the Occurrence of Spotting in PMB Bakti Ibu Martapura. J Multidisciplinary Research Nation. 2025;1(8):1327–34.

Isnaeni NFT. Eterminant of Drop Out Incidence of Contraceptive Use in Fertile Age Couples (PUS) at Aeng Towa Community Health Center, Takalar Regency in 2021. Hasanuddin University.; 2022.

Sari DO. Relationship of Risk Factor Analysis to Melasma Incidence in Patients at Dr. H. Abdul Moeloek Regional Hospital. Bandar Lampung: Faculty of Medicine, University of Lampung; 2021.